Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2023 Jul 13:10:203-208.
doi: 10.2176/jns-nmc.2023-0023. eCollection 2023.

Efficacy of Spinal Cord Stimulation Using Differential Target Multiplexed Stimulation for Intractable Pain of Hereditary Neuropathy with Liability to Pressure Palsies: A Case Report

Affiliations
Case Reports

Efficacy of Spinal Cord Stimulation Using Differential Target Multiplexed Stimulation for Intractable Pain of Hereditary Neuropathy with Liability to Pressure Palsies: A Case Report

Takafumi Tanei et al. NMC Case Rep J. .

Abstract

Hereditary neuropathy with liability to pressure palsies is an extremely rare genetic disorder; it is an autosomal dominant disorder with a high incidence of neuropathic and/or musculoskeletal pain. A case of achieving pain relief by spinal cord stimulation using differential target multiplexed stimulation for a 44-year-old female patient with hereditary neuropathy with liability to pressure palsies who was experiencing severe pain in her back, face, and all four limbs is presented. In her early teens, the initial symptoms were numbness and weakness of a limb after movement, which improved spontaneously. Transient pain in her back followed by systemic and persistent muscle weakness and pain developed. Deletion of the gene for peripheral myelin protein 22 was detected by peripheral nerve biopsy. The diagnosis of hereditary neuropathy with liability to pressure palsies was made in her early thirties. A spinal cord stimulation trial was performed because her severe pain continued despite administering many medications. Therefore, two spinal cord stimulation systems were implanted at the C3-5 and Th8-9 levels by two procedures. Pain in her back, arms, and legs decreased from 8 to 1, 5 to 1, and 6 to 2 on the numerical rating scale, respectively. Furthermore, opioid usage was tapered. The pain of hereditary neuropathy with liability to pressure palsies has a complicated pathogenesis and is resistant to pharmacological treatment. Spinal cord stimulation using differential target multiplexed stimulation may be a viable treatment option.

Keywords: DTM; hereditary neuropathy with liability to pressure palsies; neuropathic pain; spinal cord stimulation.

PubMed Disclaimer

Conflict of interest statement

The authors have no conflicts of interest directly relevant to this article's content.

Figures

Fig. 1
Fig. 1
The schematic diagram shows the pain locations, including her back, all four limbs, and face. The numerical rating scale scores for back pain are 8 (red color), and bilateral arms and legs are 5 and 6, respectively (gray color).
Fig. 2
Fig. 2
A: Magnetic resonance image shows disc herniations at C5/6 and C6/7 (thin arrow) and syringomyelia at the Th2 level (thick arrow). B, C: Dynamic magnetic resonance images demonstrate protruding disc herniations compressing the spinal cord (B: retroflexion, C: anteflexion).
Fig. 3
Fig. 3
A, B: Two percutaneous, 8-contact leads of the first implantation are located at the C3-5 levels (A: anterior-posterior view, B: lateral view). C, D: Two additional percutaneous 8-contact leads of the second implantation are located at the Th8-9 levels (C: anterior-posterior view, D: lateral view). E: Finally, four leads and two implantable pulse generators are implanted.

References

    1. de Oliveira AP, Pereira RC, Onofre PT, et al. : Clinical and neurophysiological features of the hereditary neuropathy with liability to pressure palsy due to the 17p11.2 deletion. Arq Neuropsiquiatr 74: 99-105, 2016 - PubMed
    1. Dubourg O, Mouton P, Brice A, LeGuern E, Bouche P: Guidelines for diagnosis of hereditary neuropathy with liability to pressure palsies. Neuromuscul Disord 10: 206-208, 2000 - PubMed
    1. Luigetti M, Del Grande A, Conte A, et al. : Clinical, neurophysiological and pathological findings of HNPP patients with 17p12 deletion: a single-centre experience. J Neurol Sci 341: 46-50, 2014 - PubMed
    1. Koehler PJ: Hereditary neuropathy with liability to pressure palsies: the first publication (1947). Neurology 60: 1211-1213, 2003 - PubMed
    1. Chance PF, Alderson MK, Leppig KA, et al. : DNA deletion associated with hereditary neuropathy with liability to pressure palsies. Cell 72: 143-151, 1993 - PubMed

Publication types

LinkOut - more resources